Cite
Coronavirus Disease 2019 (COVID-19) Severity Among Women of Reproductive Age With Symptomatic Laboratory-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Pregnancy Status—United States, 1 January 2020–25 December 2021
MLA
Strid, Penelope, et al. “Coronavirus Disease 2019 (COVID-19) Severity Among Women of Reproductive Age With Symptomatic Laboratory-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Pregnancy Status—United States, 1 January 2020–25 December 2021.” Clinical Infectious Diseases, vol. 75, Oct. 2022, pp. S317–25. EBSCOhost, https://doi.org/10.1093/cid/ciac479.
APA
Strid, P., Zapata, L. B., Tong, V. T., Zambrano, L. D., Woodworth, K. R., Riser, A. P., Galang, R. R., Gilboa, S. M., & Ellington, S. R. (2022). Coronavirus Disease 2019 (COVID-19) Severity Among Women of Reproductive Age With Symptomatic Laboratory-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Pregnancy Status—United States, 1 January 2020–25 December 2021. Clinical Infectious Diseases, 75, S317–S325. https://doi.org/10.1093/cid/ciac479
Chicago
Strid, Penelope, Lauren B Zapata, Van T Tong, Laura D Zambrano, Kate R Woodworth, Aspen P Riser, Romeo R Galang, Suzanne M Gilboa, and Sascha R Ellington. 2022. “Coronavirus Disease 2019 (COVID-19) Severity Among Women of Reproductive Age With Symptomatic Laboratory-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Pregnancy Status—United States, 1 January 2020–25 December 2021.” Clinical Infectious Diseases 75 (October): S317–25. doi:10.1093/cid/ciac479.